Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
mi
from
Toledo, OH
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Toledo, OH
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
mi
from
Tulsa, OK
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
mi
from
Cordova, TN
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Cordova, TN
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
mi
from
Memphis, TN
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
mi
from
Houston, TX
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
mi
from
Richmond, VA
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
mi
from
Kirkland, WA
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Kirkland, WA
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
mi
from
Milwaukee, WI
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity
Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity
Status: Enrolling
Updated:  8/6/2013
mi
from
Chicago, IL
Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity
Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity
Status: Enrolling
Updated: 8/6/2013
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity
Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity
Status: Enrolling
Updated:  8/6/2013
mi
from
Chicago, IL
Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity
Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity
Status: Enrolling
Updated: 8/6/2013
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated:  8/6/2013
mi
from
Santa Clara, CA
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated:  8/6/2013
mi
from
Aurora, CO
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated:  8/6/2013
mi
from
Washington,
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated:  8/6/2013
mi
from
Park Ridge, IL
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
Clinical Research Facility
mi
from
Park Ridge, IL
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated:  8/6/2013
mi
from
Louisville, KY
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated:  8/6/2013
mi
from
Metairie, LA
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated:  8/6/2013
mi
from
Boston, MA
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated:  8/6/2013
mi
from
Ann Arbor, MI
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated:  8/6/2013
mi
from
New York, NY
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated:  8/6/2013
mi
from
Cleveland, OH
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated:  8/6/2013
mi
from
Philadelphia, PA
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
IRT in Infants With Intestinal Perforation
Immunoreactive Trypsinogen in Infants With Intestinal Perforation
Status: Enrolling
Updated:  8/7/2013
mi
from
St. Paul, MN
IRT in Infants With Intestinal Perforation
Immunoreactive Trypsinogen in Infants With Intestinal Perforation
Status: Enrolling
Updated: 8/7/2013
Childrens Hospitals And Clinics Of Minnesota
mi
from
St. Paul, MN
Click here to add this to my saved trials
An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate and Severe Hepatic Insufficiency and Healthy Volunteers
An Open-Label Study to Compare the Pharmacokinetic Profiles of a Single Dose of Ferriprox® in Subjects With Impaired Hepatic Function and Healthy Volunteers
Status: Enrolling
Updated:  8/7/2013
mi
from
Miami, FL
An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate and Severe Hepatic Insufficiency and Healthy Volunteers
An Open-Label Study to Compare the Pharmacokinetic Profiles of a Single Dose of Ferriprox® in Subjects With Impaired Hepatic Function and Healthy Volunteers
Status: Enrolling
Updated: 8/7/2013
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate and Severe Hepatic Insufficiency and Healthy Volunteers
An Open-Label Study to Compare the Pharmacokinetic Profiles of a Single Dose of Ferriprox® in Subjects With Impaired Hepatic Function and Healthy Volunteers
Status: Enrolling
Updated:  8/7/2013
mi
from
Orlando, FL
An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate and Severe Hepatic Insufficiency and Healthy Volunteers
An Open-Label Study to Compare the Pharmacokinetic Profiles of a Single Dose of Ferriprox® in Subjects With Impaired Hepatic Function and Healthy Volunteers
Status: Enrolling
Updated: 8/7/2013
Orlando Clinical Research Center
mi
from
Orlando, FL
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
Phoenix, AZ
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Carl T. Hayden VA Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
Phoenix, AZ
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
HOPE Research Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
Fresno, CA
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Dr. Jagpreet S. Mukker
mi
from
Fresno, CA
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
Mather, CA
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
VA Northern California Health Care Sytem
mi
from
Mather, CA
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
New Haven, CT
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
North Amercian Center for Limb Preservation
mi
from
New Haven, CT
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
Miami, FL
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
University of Miami Miller School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
South Miami, FL
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Doctors Research Network
mi
from
South Miami, FL
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
Tamarac, FL
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
South Florida Wound Care Group
mi
from
Tamarac, FL
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
Saginaw, MI
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Covenant Wound Healing Center
mi
from
Saginaw, MI
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
Las Vegas, NV
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Advanced Foot and Ankle Center
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
Stony Brook, NY
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
Erie, PA
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Saint Vincent Health Center
mi
from
Erie, PA
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
Tallin,
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
East-Tallinn Central Hospital Department of Rheumatology
mi
from
Tallin,
Click here to add this to my saved trials
Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
Status: Enrolling
Updated:  8/13/2013
mi
from
Brooklyn, NY
Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
Status: Enrolling
Updated: 8/13/2013
New York Methodist Hospital
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome
Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome
Status: Enrolling
Updated:  8/27/2013
mi
from
Columbus, OH
Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome
Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome
Status: Enrolling
Updated: 8/27/2013
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients
An Open Label, Single-dose, Parallel Group Study to Assess the Pharmacokinetics and Tolerability of a Single Oromucosal Dose of 4 Sprays of Sativex(Containing 10.8 mg Delta-9-tetrahydrocannabinol [THC] and 10 mg Cannabidiol [CBD]) in Patients With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic Function.
Status: Enrolling
Updated:  8/28/2013
mi
from
Anaheim, CA
Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients
An Open Label, Single-dose, Parallel Group Study to Assess the Pharmacokinetics and Tolerability of a Single Oromucosal Dose of 4 Sprays of Sativex(Containing 10.8 mg Delta-9-tetrahydrocannabinol [THC] and 10 mg Cannabidiol [CBD]) in Patients With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic Function.
Status: Enrolling
Updated: 8/28/2013
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
Click here to add this to my saved trials
Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients
An Open Label, Single-dose, Parallel Group Study to Assess the Pharmacokinetics and Tolerability of a Single Oromucosal Dose of 4 Sprays of Sativex(Containing 10.8 mg Delta-9-tetrahydrocannabinol [THC] and 10 mg Cannabidiol [CBD]) in Patients With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic Function.
Status: Enrolling
Updated:  8/28/2013
mi
from
Miami, FL
Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients
An Open Label, Single-dose, Parallel Group Study to Assess the Pharmacokinetics and Tolerability of a Single Oromucosal Dose of 4 Sprays of Sativex(Containing 10.8 mg Delta-9-tetrahydrocannabinol [THC] and 10 mg Cannabidiol [CBD]) in Patients With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic Function.
Status: Enrolling
Updated: 8/28/2013
Clinical Pharmacology of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Open-Label Extension Study of GSK1605786A
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated:  8/29/2013
mi
from
Glendale, AZ
Open-Label Extension Study of GSK1605786A
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
GSK Investigational Site
mi
from
Glendale, AZ
Click here to add this to my saved trials
Open-Label Extension Study of GSK1605786A
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated:  8/29/2013
mi
from
Anaheim, CA
Open-Label Extension Study of GSK1605786A
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
GSK Investigational Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
Open-Label Extension Study of GSK1605786A
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated:  8/29/2013
mi
from
Aurora, CO
Open-Label Extension Study of GSK1605786A
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
GSK Investigational Site
mi
from
Aurora, CO
Click here to add this to my saved trials
Open-Label Extension Study of GSK1605786A
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated:  8/29/2013
mi
from
New Haven, CT
Open-Label Extension Study of GSK1605786A
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
GSK Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
Open-Label Extension Study of GSK1605786A
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated:  8/29/2013
mi
from
Jacksonville, FL
Open-Label Extension Study of GSK1605786A
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
GSK Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Open-Label Extension Study of GSK1605786A
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated:  8/29/2013
mi
from
Roswell, GA
Open-Label Extension Study of GSK1605786A
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
GSK Investigational Site
mi
from
Roswell, GA
Click here to add this to my saved trials
Open-Label Extension Study of GSK1605786A
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated:  8/29/2013
mi
from
Joliet, IL
Open-Label Extension Study of GSK1605786A
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
GSK Investigational Site
mi
from
Joliet, IL
Click here to add this to my saved trials
Open-Label Extension Study of GSK1605786A
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated:  8/29/2013
mi
from
Indianapolis, IN
Open-Label Extension Study of GSK1605786A
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
GSK Investigational Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Open-Label Extension Study of GSK1605786A
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated:  8/29/2013
mi
from
Louisville, KY
Open-Label Extension Study of GSK1605786A
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
GSK Investigational Site
mi
from
Louisville, KY
Click here to add this to my saved trials